ACGJ — ACI Global Share Price
Last Trade - 00:00- $0.24m
- $0.44m
- $1.17m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 30th Sep | Unit | 1998 | 1999 | 2000 | 2001 | 2002 | 2003E | 2004E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.38 | 1.12 | 0.76 | 1.11 | 1.44 | n/a | n/a | 13.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ACI Global Corp., formerly Par Advance Technologies Corp., a clinical-stage biopharmaceutical company engaged in the development of natural and novel peptides for the treatment or prevention of infections due to multi-drug resistant bacteria and fungi. The Company's drug candidates are proprietary synthetic and natural peptides (small proteins). Antecedents for these compounds occur in nature as part of the immune system of animals, insects and plants. Generally, the peptides bind to and kill harmful microorganisms and cancer cells. P113D, the Company's product candidate for cystic fibrosis, has been awarded Orphan Drug designation by the United States Food and Drug Administration (FDA). Demegen is also developing a novel, synthetic antimicrobial peptide in a rinse formulation for the treatment and prevention of oral candidiasis. The Company's peptide technology can also be used to prevent serious damage to crops caused by fungal and bacterial diseases.
Directors
- Last Annual
- September 30th, 2002
- Last Interim
- December 31st, 2002
- Incorporated
- September 16th, 1987
- Public Since
- April 14th, 1994
- No. of Shareholders
- 503
- No. of Employees
- 3
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 47,367,778
- Address
- 16 N Water St # 106, GREENWICH, 06830-5834
- Web
- Phone
- +1 2039875356
- Auditors
- Ernst & Young LLP
Similar to ACGJ
AEON GLOBAL HEALTH ORD
Pink Sheets on Nasdaq
BANYAN ORD
Pink Sheets on Nasdaq
BIONEXUS GENE LAB ORD
Pink Sheets on Nasdaq
GENELINK ORD
Pink Sheets on Nasdaq
GLOBAL WHOLEHEALTH PARTNERS ORD
Pink Sheets on Nasdaq
FAQ
As of Today at 19:55 UTC, shares in ACI Global are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in ACI Global last closed at $0.01 and the price had moved by +499900% over the past 365 days. In terms of relative price strength the ACI Global share price has outperformed the S&P500 Index by +386699.63% over the past year.
There is no consensus recommendation for this security.
ACI Global does not currently pay a dividend.
ACI Global does not currently pay a dividend.
ACI Global does not currently pay a dividend.
To buy shares in ACI Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in ACI Global had a market capitalisation of $0.24m.
Here are the trading details for ACI Global:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ACGJ
Based on an overall assessment of its quality, value and momentum ACI Global is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ACI Global. Over the past six months, its share price has outperformed the S&P500 Index by +463633.38%.
As of the last closing price of $0.01, shares in ACI Global were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for ACI Global.
ACI Global's management team is headed by:
- Richard Ekstrom - CFO
- Joseph Lovett -
We do not have data on ACI Global's shareholders